SCHEMBL12428386

SCHEMBL12428386

CCCCCCCCN1CCCc2cc(/C=C/C=C3\C(=O)N(c4ccccc4)N=C3C(=O)O)c3ccccc3c21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 12/20 0.38
KMT2A Q03164 11/20 0.38
MAPK1 P28482 10/20 0.38
ALDH1A1 P00352 10/20 0.38
MEN1 O00255 9/20 0.38
HTT P42858 5/20 0.38
NPSR1 Q6W5P4 2/20 0.38
MDM2 Q00987 1/20 0.38
GPR55 Q9Y2T6 1/20 0.38
L3MBTL1 Q9Y468 8/20 0.35
TDP1 Q9NUW8 8/20 0.35
POLB P06746 4/20 0.35
LMNA P02545 3/20 0.35
NSD2 O96028 1/20 0.34
HSPA1A P0DMV8 1/20 0.34
TNNI3 P19429 1/20 0.34
GRK2 P25098 1/20 0.34
DNMT1 P26358 1/20 0.34
TNNT2 P45379 1/20 0.34
TNNC1 P63316 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12428485 0.84 KMT2A (0.42) MAPTKMT2AMAPK1ALDH1A1MEN1
SCHEMBL12428330 0.81 KMT2A (0.39) MAPTKMT2AMAPK1ALDH1A1MEN1
SCHEMBL12428281 0.81 KMT2A (0.34) MAPTKMT2AMAPK1ALDH1A1MEN1
SCHEMBL12428295 0.79 APOBEC3A (0.41) MAPTKMT2AMAPK1ALDH1A1MEN1
SCHEMBL12510314 0.76 KMT2A (0.46) MAPTKMT2AMAPK1ALDH1A1MEN1
SCHEMBL12881061 0.75 MAPT (0.48) MAPTKMT2AMAPK1ALDH1A1MEN1
SCHEMBL12428196 0.73 ADRB2 (0.40) MAPTKMT2AMAPK1ALDH1A1MEN1
SCHEMBL12428398 0.73 PPARG (0.39) MAPTKMT2AMAPK1ALDH1A1MEN1
SCHEMBL12428243 0.73 PRF1 (0.37) MAPTKMT2AMAPK1ALDH1A1MEN1
SCHEMBL12428450 0.72 KMT2A (0.39) MAPTKMT2AMAPK1ALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7977570-B2 Dye-sensitized photoelectric conversion device NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2011-07-12 US disclosed
US-20090084441-A1 Dye-sensitized photoelectric conversion device NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2009-04-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090084441-A1 Dye-sensitized photoelectric conversion device CRY1, H1-5, H1-0 MAPT 4642/4885KMT2A 105/4885MAPK1 1624/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.